Arisa Akashi Sin
Lawyers
Advises corporate and financial institution clients across a broad range of capital markets transactions.
Arisa advises U.S. and non-U.S. corporate and financial institution clients on a wide variety of public and private capital markets transactions, including initial public offerings and other equity offerings, investment-grade and high-yield debt offerings, and liability management transactions. She also advises clients on governance, SEC reporting and other securities law and corporate matters.
Arisa’s practice ranges across a variety of industries, including biotech, healthcare and life sciences, fintech, technology, consumer retail and energy.
Experience
Recent Work
- Precigen $79 million preferred stock and warrants offering
- TPG Angelo Gordon debt and equity financing to DISH DBS Issuer
- MBX Biosciences $188 million IPO
- Precigen $34 million follow-on offering
- Sealed Air $400 million senior notes offering and concurrent tender offer
- Home Depot $10 billion notes offering
- Verisk $600 million senior notes offering and concurrent tender offer
- Oculis Holding $100 million at-the-market offering
- Tellurian $366.1 million at-the-market offering
- Sealed Air $425 million senior notes offering and concurrent tender offer
- ODDITY Tech $424 million IPO
- Oculis Holding $40.25 million debut equity offering
- Honeywell €1.15 billion senior notes offering
- Honeywell $1.75 billion senior notes offering
- Verisk $500 million senior notes offering
- European Biotech Acquisition $220 million combination with Oculis
Education
J.D., Columbia Law School
- James Kent Scholar
- Articles Editor, Columbia Business Law Review
B.S., Cognitive Neuroscience, Brown University
- magna cum laude
- Sigma Xi
Qualifications and admissions
- State of New York